Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Maximum_Gain who wrote (3852)	3/4/2000 6:55:00 AM
From: LiPolymer	Read Replies (1) \| Respond to of 4140

Hey Maximum, Thanks for the response. Yes, I can see that some may be wary of this stock considering how it's been manipulated over the past year. I also know from experience that short-sellers can be pretty obstinate about their position. Even after factoring out all the various convertibles and warrants that have been hedged, somebody is still short a ton on this one, but exactly who does not matter much to me. If you say you covered, then I cannot prove it otherwise. So be it. The stock is in a holding pattern right now, with neither side of bid/ask acting very aggressively. It seems very clear there is an overhang on the industry now due to the VISX debacle. I believe LTK differentiates significantly from LASIK/PRK and as such can carve out a niche in the market. Doctors are interested in the machine and it is much more economical and safe than LASIK for treating hyperopia. It can also be used to correct a botched LASIK overcorrection. The big question for me is whether this procedure can be priced/marketed successfully to correct presbyopia. If so, it will be huge and I will be buying a lot more. With the FDA approval pending, the company, as well as the stock, is very much in a quiet period right now. The company has the capital it needs to successfully complete the product rollout. Many will be interested in hearing about the size of the backlog of orders once FDA approval is obtained. Regards, Gary